Vaxcyte Reports Third Quarter 2022 Financial Results and Provides Business Update by Seini Moimoi | Nov 7, 2022 | Portfolio News
RxSight, Inc. Reports Third Quarter 2022 Financial Results by Seini Moimoi | Nov 7, 2022 | Portfolio News
CuraSen Therapeutics Announces First Patients Treated with Novel Combination Therapy (CST-2032/CST-107) in Phase 2a Study of Mild Cognitive Impairment (MCI) or Mild Dementia Due to Parkinson’s or Alzheimer’s Disease by Seini Moimoi | Nov 7, 2022 | Portfolio News
Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics by Seini Moimoi | Nov 7, 2022 | Portfolio News
Theseus Pharmaceuticals Announces Business and Pipeline Highlights and Reports Third Quarter 2022 Financial Results by Seini Moimoi | Nov 3, 2022 | Portfolio News
